Page 304 - Chiral Separation Techniques
P. 304

Refernces   283
             [15] Monahan, B.P., Ferguson, C.L., Killeavy, E.S., Lloyd, B.K, J., Cantilena, L.R., J. Am. Med. Assoc.,
                264, (1990) 2788–2790.
             [16] Proposal to Withdraw Approval of Two New Drug Applications and One Abbreviated New Drug
                Application; Terfenadine, Hoechst Marion Rousssel, Inc and Baker Norton Pharmaceuticals, Fed
                Regist., Docket No. 96N-0512, 1997, 1998.  Part 216 Pharmacy Compounding, Drug Products
                Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness, Cite: 216.24.
             [17] Policy on Period of Marketing Exclusivity for Newly Approved Drug Products with Enantiomer
                Active Ingredients; Request for Comments, (1997) Docket No. 97N-0002.
             [18] Applications for FDA Approval to Market a New Drug or an Antiobiotic Drug, Content and format
                of an Application, CFR, Title 21, Volume 5, Part 314, Section 314.50 (1998).
             [19] Applications for FDA Approval to Market a New Drug, New Drug Product Exclusivity, (1999)
                CFR, Title 21, Part 314, Volume 5, Section 314.108.
             [20] Fixed-Combination Prescription Drug for Humans, (1999), CFR, Title 21, Part 300, Volume 5, Sec-
                tion 300.50.
             [21] Caldwell, J., (1995) Regulation of Chiral Drugs, Pharmaceutical News, 2, 22–23. Caldwell, J.
                (1995) Chiral Pharmacology and the Regulation of New Drugs, Chem. and Industry, 5, 176–179.
             [22] Nicoud R.M. and M. Bailly, in Proceedings of the 9th Symposium on Preparative and Industrial
                Chromatography “Prep 92”, INPL, Nancy, France, 1992, pp. 205–220.
             [23] Broughton D.B., US Patent 2985 589(1961).
             [24] Balannec B. and Hotier G., “From batch to countercurrent chromatography”, in Preparative and
                Production Scale Chromatography, G. Ganetsos and P.E. Barker (Editors), Marcel Dekker, New
                York, 1993.
             [25] Nicoud R.M., Fuchs G., Adam P., Bailly M., Küsters E., Antia, F.D., Reuille R. and Schmid E., Chi-
                rality, 5 (1993) 267. Nicoud R.M., LC-GC Int., volume 6, Number 10, October 1993.
             [26] Nicoud R.M., Bailly M., Kinkel J.N., Devant R., Hampe T., and Küsters E., in R.M. Nicoud (Edi-
                tor), Simulated Moving Bed: Basics and applications, INPL, Nancy, France, 1993, pp. 65–88.
             [27] Blehaut J., Charton F., Nicoud R.M., LC-GC Intl, Vol. 9, No. 4, pp. 228–238, 1996.
             [28] Martin and Kuhn, Ztschr. elektrokem., bd. 47, no 3, 1941.
             [29] Hotier G. and Balannec G., Xvème conférence des Arts Chimiques, 5/8 Décembre 1989.
             [30] Negawa M. and Shoji F., J. Chrom., 590, 113–117 (1992).
             [31] Fuchs G., Nicoud R.M. and M. Bailly, in Proceedings of the 9th Symposium on Preparative and
                Industrial Chromatography “Prep 92”, INPL, Nancy, France, 1992, pp. 205-220.
             [32] Nicoud R.M., Chem. Eng. 1992, 21.
             [33] Devant R.M., Jonas R., Schultre M., Keil A. and Charton F., J. Prakt. Chem., 339, pp. 315–321,
                1997.
             [34] Francotte E., Wolf R.M., Chirality, 3, p. 43, 1991.
             [35] Ching C.B., Lim B.G., Lee E.J.D., Ng S.C., J. of Chrom., 634, pp. 215–219, 1993.
             [36] Ikeda H. and Murata K., 4th Symposium on Chiral Discrimination, September 1993.
             [37] Nicoud R.M., Proceedings of the Chiral Europe 96, Strasbourg, 14–15 October 1996, Spring Inno-
                vation Ltd Publisher, Cheshire, SK7 1BA, 1996.
             [38] Kinkel J.N., Proceedings of Chiral Europe 95, 28–29 Sept. 1995, London, Published by Spring
                Innovation Ltd, Cheshire, SK7 1BA, England, 1995.
             [39] Gattuso M.J., Chimica Oggi, September 1995.
             [40] Gattuso M.J., Mc Culloch, House D.W., Bauman W.M. and Gottschall K., Pharmaceutical technol-
                ogy Europe, June 1996.
             [41] Guest D.W. – Evaluation of simulated moving bed chromatography for pharmaceutical process
                development., J. of Chromatography A, 760 (1997), pp 159–162.
             [42] Cavoy E., Deltent M.F., Lehoucq S., Miggiano D., J. of Chrom., 769, pp. 49–57, 1997.
             [43] Küsters E., Proceedings of Chiral Europe 95, Published by Spring Innovation Ltd., Stockport, Eng-
                land, 1995.
             [44] Francotte E., Proceedings of Chiral Europe 96, Strasbourg 14–15 October 1996, Published by
                Spring Innovations Ltd, Stocport, England, 1996.
             [45] Nagamatsu, Proceedings of Chiral Europe 96, Strasbourg 14–15 October 1996, Published by Spring
                Innovations Ltd, Stocport, England, 1996.
             [46] Charton F., Nicoud R.M., J. of Chrom. A., 702, pp. 97–112, 1995.
             [47] Pais L.S., Loureiro J.M., Rodrigues A.E., Chem. Eng. Sci., 52, p. 245, 1997.
   299   300   301   302   303   304   305   306   307   308   309